Mitsuhiro Ibe
President bei ZERIA PHARMACEUTICAL CO., LTD.
Vermögen: 1 Mio $ am 31.03.2024
Aktive Positionen von Mitsuhiro Ibe
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ZERIA PHARMACEUTICAL CO., LTD. | Chief Operating Officer | 01.06.2014 | - |
Director/Board Member | 01.06.2010 | - | |
President | 01.06.2014 | - | |
Comptroller/Controller/Auditor | 01.04.2010 | 01.04.2011 | |
Sales & Marketing | 01.04.2011 | 01.06.2011 | |
Tillotts Pharma AG
Tillotts Pharma AG Pharmaceuticals: MajorHealth Technology Tillotts Pharma AG manufactures pharmaceuticals for treatment of gastrointestinal diseases. The firm specializes in the therapy of the lower gastrointestinal tract. It offers Asacol, Entocort, Colpermin, Tillhepo and VistaPrep. The company was founded in 1986 and is headquartered in Ziefen, Switzerland. | Director/Board Member | - | - |
Karriereverlauf von Mitsuhiro Ibe
Statistik
International
Schweiz | 2 |
Japan | 2 |
Operativ
Director/Board Member | 2 |
Comptroller/Controller/Auditor | 1 |
Chief Operating Officer | 1 |
Sektoral
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ZERIA PHARMACEUTICAL CO., LTD. | Health Technology |
Private Unternehmen | 1 |
---|---|
Tillotts Pharma AG
Tillotts Pharma AG Pharmaceuticals: MajorHealth Technology Tillotts Pharma AG manufactures pharmaceuticals for treatment of gastrointestinal diseases. The firm specializes in the therapy of the lower gastrointestinal tract. It offers Asacol, Entocort, Colpermin, Tillhepo and VistaPrep. The company was founded in 1986 and is headquartered in Ziefen, Switzerland. | Health Technology |
- Börse
- Insiders
- Mitsuhiro Ibe
- Erfahrung